Stay updated on MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.4, replacing the previous v3.6.3, indicating a new version of the study page.
    Difference
    0.1%
    Check dated 2026-07-25T12:32:12.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3, indicating a newer version of the page.
    Difference
    0.1%
    Check dated 2026-07-03T23:40:15.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The page revision changed from v3.6.0 to v3.6.2, signaling a backend version update. No user-facing content or behavior was modified.
    Difference
    0.1%
    Check dated 2026-06-26T20:23:31.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Recruitment status updated to not currently enrolling participants. New navigation sections—How to Read a Study Record, Common Questions, and How to Join a Study—were added, and the Intervention/Treatment heading formatting was updated along with the revision label from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T11:43:52.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The page’s revision number was updated from v3.5.4 to v3.5.5, signaling a backend release with no impact on the study data or user-facing information.
    Difference
    0.1%
    Check dated 2026-06-05T08:29:53.000Z thumbnail image
  9. Check
    83 days ago
    Change Detected
    Summary
    The page revision label changes from v3.5.3 to v3.5.4, indicating a new version of the page rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-05-14T23:08:08.000Z thumbnail image

Stay in the know with updates to MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page.